Testing effectiveness (Phase 2)UnknownNCT01812096
What this trial is testing
Study of Subcutaneous Versus Intravenous Administration of Bortezomib in Patients With Multiple Myeloma in China
Who this might be right for
Multiple Myeloma Proved by Laboratory Tests
The First Affiliated Hospital of Soochow University 20